Insider Buy/Sell Details for the Biotechnology Industry — April 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1153)
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
3,811
Price
$0.29
Total Value
$1.11K
Shares Held After
117,781
% of Holdings
3.1%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Hamilton James C — Chief Medical Officer
Shares
10,000
Price
$75.00
Total Value
$750.00K
Shares Held After
226,958
% of Holdings
4.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Neman-Ebrahim Yousha — Chief Clinical Officer
Shares
500
Price
$4.88
Total Value
$2.44K
Shares Held After
134,760
% of Holdings
0.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.74
Total Value
$261.88K
Shares Held After
386,470
% of Holdings
4.7%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
2,754
Price
$29.62
Total Value
$81.57K
Shares Held After
251,685
% of Holdings
1.1%
Immunovant, Inc. (IMVT)
Girao Tiago — Chief Financial Officer
Shares
25,760
Price
$29.62
Total Value
$763.01K
Shares Held After
247,596
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$576.33
Total Value
$207.48K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
143
Price
$575.26
Total Value
$82.26K
Shares Held After
40,873
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
521
Price
$574.71
Total Value
$299.42K
Shares Held After
41,016
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
567
Price
$573.38
Total Value
$325.11K
Shares Held After
41,537
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,688
Price
$572.60
Total Value
$2.11M
Shares Held After
42,104
% of Holdings
8.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,921
Price
$571.59
Total Value
$1.67M
Shares Held After
45,792
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,055
Price
$570.76
Total Value
$602.16K
Shares Held After
48,713
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
245
Price
$569.62
Total Value
$139.56K
Shares Held After
49,768
% of Holdings
0.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
21
Price
$169.56
Total Value
$3.56K
Shares Held After
9,666
% of Holdings
0.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
54
Price
$168.43
Total Value
$9.10K
Shares Held After
9,687
% of Holdings
0.6%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
373
Price
$167.37
Total Value
$62.43K
Shares Held After
9,741
% of Holdings
3.7%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
127
Price
$166.56
Total Value
$21.15K
Shares Held After
10,114
% of Holdings
1.2%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
158
Price
$165.38
Total Value
$26.13K
Shares Held After
10,241
% of Holdings
1.5%
BELITE BIO, INC (BLTE)
MATA NATHAN L. — Chief Scientific Officer
Shares
267
Price
$164.47
Total Value
$43.91K
Shares Held After
10,399
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$576.62
Total Value
$69.19K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
535
Price
$574.79
Total Value
$307.51K
Shares Held After
19,360
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
321
Price
$573.51
Total Value
$184.10K
Shares Held After
19,895
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,976
Price
$572.66
Total Value
$2.28M
Shares Held After
20,216
% of Holdings
16.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
3,325
Price
$571.64
Total Value
$1.90M
Shares Held After
24,192
% of Holdings
12.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,079
Price
$570.82
Total Value
$615.91K
Shares Held After
27,517
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
280
Price
$569.63
Total Value
$159.50K
Shares Held After
28,596
% of Holdings
1.0%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
388,067
% of Holdings
0.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
56,450
% of Holdings
0.2%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
156,869
% of Holdings
0.1%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
100
Price
$30.03
Total Value
$3.00K
Shares Held After
66,083
% of Holdings
0.2%
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
Heshmatpour Amir F — Director
Shares
10,000
Price
$4.90
Total Value
$49.00K
Shares Held After
3,052,000
% of Holdings
0.3%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Apel Daniel Joseph — Chief Financial Officer
Shares
8,730
Price
$71.92
Total Value
$627.86K
Shares Held After
162,905
% of Holdings
5.1%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Apel Daniel Joseph — Chief Financial Officer
Shares
1,157
Price
$70.45
Total Value
$81.51K
Shares Held After
171,635
% of Holdings
0.7%
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Apel Daniel Joseph — Chief Financial Officer
Shares
3,208
Price
$70.11
Total Value
$224.91K
Shares Held After
172,792
% of Holdings
1.8%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
165,150
Price
$15.77
Total Value
$2.60M
Shares Held After
2,402,095
% of Holdings
6.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$14.13
Total Value
$269.32K
Shares Held After
390,808
% of Holdings
4.7%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
300
Price
$90.00
Total Value
$27.00K
Shares Held After
61,202
% of Holdings
0.5%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Gibson Christopher — Director
Shares
40,000
Price
$3.61
Total Value
$144.40K
Shares Held After
906,556
% of Holdings
4.2%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
12
Price
$90.08
Total Value
$1.08K
Shares Held After
674,944
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
88
Price
$90.08
Total Value
$7.93K
Shares Held After
3,899,829
% of Holdings
0.0%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
5,900
Price
$89.96
Total Value
$530.76K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
364
Price
$575.85
Total Value
$209.61K
Shares Held After
18,996
% of Holdings
1.9%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
7,000
Price
$30.05
Total Value
$210.38K
Shares Held After
388,167
% of Holdings
1.8%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
7,000
Price
$30.05
Total Value
$210.36K
Shares Held After
156,969
% of Holdings
4.3%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
7,000
Price
$30.05
Total Value
$210.36K
Shares Held After
56,450
% of Holdings
11.0%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
500
Price
$30.00
Total Value
$15.00K
Shares Held After
56,450
% of Holdings
0.9%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
7,001
Price
$30.05
Total Value
$210.40K
Shares Held After
66,083
% of Holdings
9.6%
ProMIS Neurosciences Inc. (PMN)
Kirwin Patrick D. — Director
Shares
4,000
Price
$11.33
Total Value
$45.32K
Shares Held After
4,653
% of Holdings
86.0%
Axsome Therapeutics, Inc. (AXSM)
Maizel Ari — Chief Commercial Officer
Shares
7,500
Price
$182.42
Total Value
$1.37M
Shares Held After
0
% of Holdings
100.0%
Showing 201–250 of 1153 transactions (page 5 of 24)